339 related articles for article (PubMed ID: 18160433)
21. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.
Lodoen M; Ogasawara K; Hamerman JA; Arase H; Houchins JP; Mocarski ES; Lanier LL
J Exp Med; 2003 May; 197(10):1245-53. PubMed ID: 12756263
[TBL] [Abstract][Full Text] [Related]
22. Myd88 Initiates Early Innate Immune Responses and Promotes CD4 T Cells during Coronavirus Encephalomyelitis.
Butchi N; Kapil P; Puntambekar S; Stohlman SA; Hinton DR; Bergmann CC
J Virol; 2015 Sep; 89(18):9299-312. PubMed ID: 26136579
[TBL] [Abstract][Full Text] [Related]
23. The role of the NKG2D immunoreceptor in immune cell activation and natural killing.
Jamieson AM; Diefenbach A; McMahon CW; Xiong N; Carlyle JR; Raulet DH
Immunity; 2002 Jul; 17(1):19-29. PubMed ID: 12150888
[TBL] [Abstract][Full Text] [Related]
24. NKG2D signaling and host defense after mouse hepatitis virus infection of the central nervous system.
Walsh KB; Lodoen MB; Lanier LL; Lane TE
Adv Exp Med Biol; 2006; 581():369-72. PubMed ID: 17037561
[No Abstract] [Full Text] [Related]
25. MHV infection of the CNS: mechanisms of immune-mediated control.
Marten NW; Stohlman SA; Bergmann CC
Viral Immunol; 2001; 14(1):1-18. PubMed ID: 11270593
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-15 mediates protection against experimental tuberculosis: a role for NKG2D-dependent effector mechanisms of CD8+ T cells.
Rausch A; Hessmann M; Hölscher A; Schreiber T; Bulfone-Paus S; Ehlers S; Hölscher C
Eur J Immunol; 2006 May; 36(5):1156-67. PubMed ID: 16619285
[TBL] [Abstract][Full Text] [Related]
27. The expression and function of NKG2D molecule on intrahepatic CD8+ T cells in chronic viral hepatitis.
Kennedy PT; Gehring AJ; Nowbath A; Selden C; Quaglia A; Dhillon A; Dusheiko G; Bertoletti A
J Viral Hepat; 2008 Dec; 15(12):901-9. PubMed ID: 19087227
[TBL] [Abstract][Full Text] [Related]
28. The art of survival during viral persistence.
Stohlman SA; Ramakrishna C; Tschen SI; Hinton DR; Bergmann CC
J Neurovirol; 2002 Dec; 8 Suppl 2():53-8. PubMed ID: 12491152
[TBL] [Abstract][Full Text] [Related]
29. NKG2D blockade prevents autoimmune diabetes in NOD mice.
Ogasawara K; Hamerman JA; Ehrlich LR; Bour-Jordan H; Santamaria P; Bluestone JA; Lanier LL
Immunity; 2004 Jun; 20(6):757-67. PubMed ID: 15189740
[TBL] [Abstract][Full Text] [Related]
30. Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
Karimi M; Cao TM; Baker JA; Verneris MR; Soares L; Negrin RS
J Immunol; 2005 Dec; 175(12):7819-28. PubMed ID: 16339517
[TBL] [Abstract][Full Text] [Related]
31. Selection of CD8+ T cells with highly focused specificity during viral persistence in the central nervous system.
Marten NW; Stohlman SA; Smith-Begolka W; Miller SD; Dimacali E; Yao Q; Stohl S; Goverman J; Bergmann CC
J Immunol; 1999 Apr; 162(7):3905-14. PubMed ID: 10201909
[TBL] [Abstract][Full Text] [Related]
32. CCR1 deficiency increases susceptibility to fatal coronavirus infection of the central nervous system.
Hickey MJ; Held KS; Baum E; Gao JL; Murphy PM; Lane TE
Viral Immunol; 2007 Dec; 20(4):599-608. PubMed ID: 18158733
[TBL] [Abstract][Full Text] [Related]
33. Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity.
Lin X; Pease LR; Murray PD; Rodriguez M
J Immunol; 1998 Jun; 160(11):5661-8. PubMed ID: 9605173
[TBL] [Abstract][Full Text] [Related]
34. Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunction.
André MC; Sigurdardottir D; Kuttruff S; Pömmerl B; Handgretinger R; Rammensee HG; Steinle A
Int J Cancer; 2012 Oct; 131(7):1601-10. PubMed ID: 21607945
[TBL] [Abstract][Full Text] [Related]
35. Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions.
Backström E; Chambers BJ; Ho EL; Naidenko OV; Mariotti R; Fremont DH; Yokoyama WM; Kristensson K; Ljunggren HG
Eur J Immunol; 2003 Jan; 33(1):92-100. PubMed ID: 12594837
[TBL] [Abstract][Full Text] [Related]
36. NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis.
Saikali P; Antel JP; Newcombe J; Chen Z; Freedman M; Blain M; Cayrol R; Prat A; Hall JA; Arbour N
J Neurosci; 2007 Jan; 27(5):1220-8. PubMed ID: 17267578
[TBL] [Abstract][Full Text] [Related]
37. Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation.
Markiewicz MA; Carayannopoulos LN; Naidenko OV; Matsui K; Burack WR; Wise EL; Fremont DH; Allen PM; Yokoyama WM; Colonna M; Shaw AS
J Immunol; 2005 Sep; 175(5):2825-33. PubMed ID: 16116168
[TBL] [Abstract][Full Text] [Related]
38. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
Ehrlich LI; Ogasawara K; Hamerman JA; Takaki R; Zingoni A; Allison JP; Lanier LL
J Immunol; 2005 Feb; 174(4):1922-31. PubMed ID: 15699119
[TBL] [Abstract][Full Text] [Related]
39. NKG2D function protects the host from tumor initiation.
Smyth MJ; Swann J; Cretney E; Zerafa N; Yokoyama WM; Hayakawa Y
J Exp Med; 2005 Sep; 202(5):583-8. PubMed ID: 16129707
[TBL] [Abstract][Full Text] [Related]
40. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
